These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7133586)

  • 1. [Treatment of tapetoretinal dystrophy with an adenosine triphosphoric acid preparation].
    Mikhaĭlovskaia IE; Salganik RI
    Oftalmol Zh; 1982; 37(3):157-9. PubMed ID: 7133586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of adenosine triphosphoric acid for the treatment of dystrophic retinal diseases].
    Dobromyslov AN; Fursova IP
    Vestn Oftalmol; 1970; 1():64-7. PubMed ID: 5474449
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment results using the preparation ENKAD in patients with peripheral tapetoretinal abiotrophy].
    Katsnel'son LA; Maslova-Khoroshilova IP; Eliseeva RF; Dnestrova GI
    Vestn Oftalmol; 1988; 104(6):54-61. PubMed ID: 3242209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in the use of RNA in the complex treatment of tapetoretinal dystrophy].
    Shershevskaia SF; Fuks BB; Potapova LN; Levina FG; Denisova TP
    Vestn Oftalmol; 1971; 3():59-63. PubMed ID: 5160956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of the local use of komplamin and ATP in treating patients with primary and secondary optic atrophy].
    Shpak NI; Fedorova LI; Savko VV; Konovalova NV
    Oftalmol Zh; 1985; (3):159-62. PubMed ID: 4011098
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of treatment on oxygen absorption kinetics in patients with retinal dystrophy.
    Trutneva KV; Zaretskaya RB; Milyavskaya TI; Epstein IM; Bruyakina NA
    Metab Pediatr Ophthalmol; 1980; 4(4):197-200. PubMed ID: 7206908
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of central tapeto-retinal abiotrophies with FAD (flavin-adenine dinucleotide)].
    Katsnel'son LA; Trutneva KV; Osadchikh VG; Iakovlev AA; Miliavskaia TI
    Vestn Oftalmol; 1978; (6):63-7. PubMed ID: 734836
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of the combination of strophanthin and ATP in the therapy of chronic circulatory insufficiency].
    Karbasnikova GN
    Sov Med; 1974 Aug; 0(8):90-4. PubMed ID: 4428283
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specific therapeutic effect of ribonucleotides in tapetoretinal dystrophies].
    Fuks BB; Shershevskaia SF; Levina FG; Shabanova ME
    Vestn Akad Med Nauk SSSR; 1971; 26(7):63-8. PubMed ID: 5122994
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial using RNA preparations for treatment of tapeto-retinal dystrophies].
    Shershevskaia SF; Levina FG
    Vestn Akad Med Nauk SSSR; 1978; (10):40-4. PubMed ID: 706719
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of brucellosis with glutamic and adenosine triphosphoric acids].
    Otaraev IB; Otaraeva BI
    Klin Med (Mosk); 1975 Feb; 53(2):52-6. PubMed ID: 1186062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Moxisylyte in macular pathology].
    Rougier-Houssin J; Vérin P
    Bull Soc Ophtalmol Fr; 1969 Nov; 69(11):935-66. PubMed ID: 5403533
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug treatment of retinal degeneration of vascular origin].
    Klíma M; Jebavá R; Skalová D
    Cesk Oftalmol; 1971 Sep; 27(5):309-14. PubMed ID: 5110677
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experimentation with pyridoxylate in treatment of various chorioretinal degenerative disorders (50 cases)].
    Boudet C; Philippot M; Arnaud B
    Bull Soc Ophtalmol Fr; 1969 Dec; 69(12):1145-50. PubMed ID: 5402204
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of the use of vasoactive preparation pikamilon in pigmented retinal abiotrophy].
    Davydova GA; Mukha AI
    Vestn Oftalmol; 1995; 111(3):20-2. PubMed ID: 7483195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of atrophia gyrata].
    Gerding H; Hennekes R; Ullrich K
    Fortschr Ophthalmol; 1987; 84(4):358-9. PubMed ID: 3666630
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of superphonoelectrophoresis on chorioretinal dystrophy].
    Gvarishvili EP; Dushin NV
    Vestn Oftalmol; 1999; 115(4):19-21. PubMed ID: 10523961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical usefulness and efficacy of adenosine triphosphate in an emergency service].
    Roig García JJ; Jiménez Murillo LM; Clemente Millán MJ; González Barranco JM; Segura Saint-Gerons J; Montero Pérez FJ
    Rev Clin Esp; 1994 Aug; 194(8):594-8. PubMed ID: 7938837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Congenital deaf-mutism and ophthalmologic problems. Study of a group of deaf-mute-blind and deaf-mute children with tapetoretinal degeneration].
    Agenos B; Barreteau C; Carius G; Coulin A; Hovasse M
    Bull Soc Ophtalmol Fr; 1980 Mar; 80(3):265-7. PubMed ID: 7363391
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ophthalmologic problems peculiar to carriers of tapetoretinal degeneration educated in centers for the visually handicapped].
    Verin P; Moretto C
    Bull Soc Ophtalmol Fr; 1981; 81(4-5):441-3. PubMed ID: 7261231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.